Effect of atorvastatin on dynamic parameters of myocardial repolarization in healthy subjects

Ondrej Toman1, Tomas Novotny, Martina Sisakova

  • 1Department of Cardiology, University Hospital Brno, Brno, Czech Republic. ondrej.toman@atlas.cz

Insights

Single doses of atorvastatin did not alter myocardial repolarization in healthy individuals. This study confirms the drug

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Statins exhibit potential antiarrhythmic properties attributed to their pleiotropic effects.
  • Previous research suggests statins may influence cardiac electrophysiology.

Purpose of the Study:

  • To investigate the impact of atorvastatin on myocardial repolarization in healthy subjects.
  • To assess ECG parameters related to repolarization and T-wave morphology.

Main Methods:

  • A single-dose, double-blind, 3-way crossover study involving 40 healthy volunteers.
  • Administration of atorvastatin (20 mg and 80 mg) and placebo.
  • Long-term (13-hour) 12-lead ECG recordings analyzed for repolarization and T-wave morphology.

Main Results:

  • No significant drug-related changes were observed in any investigated ECG repolarization descriptors.
  • Some trends in repolarization parameters were noted but did not reach statistical significance.
  • Analysis included dynamic repolarization parameters and T-wave morphology descriptors.

Conclusions:

  • Single doses of atorvastatin did not affect repolarization heterogeneity compared to placebo.
  • The findings support a safe profile for atorvastatin with limited proarrhythmic potential in healthy individuals.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...